Publications by authors named "Ben Staal"

Claim this Profile
M
Multiplexed glycan immunofluorescence identification of pancreatic cancer cell subpopulations in both tumor and blood samples.
Braelyn Binkowski, Zachary Klamer, ChongFeng Gao, Ben Staal, Anna Repesh

Sci Adv· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A rigorous multi-laboratory study of known PDAC biomarkers identifies increased sensitivity and specificity over CA19-9 alone.
Brian Haab, Lu Qian, Ben Staal, Maneesh Jain, Johannes Fahrmann

Cancer Lett· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multiplexed Glycan Immunofluorescence Identification of Pancreatic Cancer Cell Subpopulations in Both Tumor and Blood Samples.
Braelyn Binkowski, Zachary Klamer, ChongFeng Gao, Ben Staal, Anna Repesh

bioRxiv· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Rigorous Multi-Laboratory Study of Known PDAC Biomarkers Identifies Increased Sensitivity and Specificity Over CA19-9 Alone.
Brian Haab, Lu Qian, Ben Staal, Maneesh Jain, Johannes Fahrmann

bioRxiv· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Framing Preference for Large and Increasing Components in Static and Dynamic Descriptions.
Henk Pander Maat, Ben Staal, Bregje Holleman

Front Psychol· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Detection of Chemotherapy-resistant Pancreatic Cancer Using a Glycan Biomarker, sTRA.
ChongFeng Gao, Luke Wisniewski, Ying Liu, Ben Staal, Ian Beddows

Clin Cancer Res· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overexpression of HGF/MET axis along with p53 inhibition induces de novo glioma formation in mice.
Yuan Qin, Anna Musket, Jianqun Kou, Johanna Preiszner, Barbara R Tschida, Ben Staal

Neurooncol Adv· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The sTRA Plasma Biomarker: Blinded Validation of Improved Accuracy Over CA19-9 in Pancreatic Cancer Diagnosis.
Ben Staal, Ying Liu, Daniel Barnett, Peter Hsueh, Zonglin He

Clin Cancer Res· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential responses of MET activations to MET kinase inhibitor and neutralizing antibody.
Jianqun Kou, Phillip R Musich, Ben Staal, Liang Kang, Yuan Qin

J Transl Med· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mining High-Complexity Motifs in Glycans: A New Language To Uncover the Fine Specificities of Lectins and Glycosidases.
Zachary Klamer, Ben Staal, Anthony R Prudden, Lin Liu, David F Smith

Anal Chem· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cartilage-specific deletion of Mig-6 results in osteoarthritis-like disorder with excessive articular chondrocyte proliferation.
Ben Staal, Bart O Williams, Frank Beier, George F Vande Woude, Yu-Wen Zhang

Proc Natl Acad Sci U S A· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Strengthening context-dependent anticancer effects on non-small cell lung carcinoma by inhibition of both MET and EGFR.
Yu-Wen Zhang, Ben Staal, Curt Essenburg, Steven Lewis, Dafna Kaufman

Mol Cancer Ther· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer-type regulation of MIG-6 expression by inhibitors of methylation and histone deacetylation.
Yu-Wen Zhang, Ben Staal, Karl J Dykema, Kyle A Furge, George F Vande Woude

PLoS One· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MET kinase inhibitor SGX523 synergizes with epidermal growth factor receptor inhibitor erlotinib in a hepatocyte growth factor-dependent fashion to suppress carcinoma growth.
Yu-Wen Zhang, Ben Staal, Curt Essenburg, Yanli Su, Liang Kang

Cancer Res· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis